Ginkgo Bioworks Holdings (DNA) Change in Account Payables (2020 - 2023)

Ginkgo Bioworks Holdings has reported Change in Account Payables for 4 years, with the latest figure at -$6.7 million in Q2 2023.

• For the quarter ending Q2 2023, Change in Account Payables rose 57.14% year-over-year to -$6.7 million; the trailing twelve-month figure through Jun 2023 stood at -$18.5 million (down 217.66% YoY), and the FY2025 full-year result was -$3.0 million, down 162.71% from the prior year.
• Change in Account Payables for Q2 2023 stood at -$6.7 million, down from $9.7 million in the prior quarter.
• The five-year high for Change in Account Payables was $26.2 million in Q1 2022, with the low at -$15.6 million in Q2 2022.
• Historically, Change in Account Payables has averaged -$525363.6 across 4 years, with a median of $516000.0 in 2021.
• The largest YoY upside for Change in Account Payables was 4987.21% in 2022 against a maximum downside of 2912.4% in 2022.
• Ginkgo Bioworks Holdings' Change in Account Payables stood at $4.3 million in 2020, then tumbled by 87.87% to $524000.0 in 2021, then slumped by 2912.4% to -$14.7 million in 2022, then soared by 54.63% to -$6.7 million in 2023.
• The last three Change in Account Payables figures came in at -$6.7 million (Q2 2023), $9.7 million (Q1 2023), and -$14.7 million (Q4 2022), per Business Quant data.